Eli Lilly's orforglipron drug under evaluation for obesity treatment
October 6, 2026
Orforglipron is a new weight loss drug by Eli Lilly currently under evaluation by the EMA. It comes in pill form and is taken once a day, making it user-friendly. Clinical trials have shown participants with obesity experienced significant weight loss. The medication also showed improvements in glycemic control. The EMA's decision on approval is pending.